Results 291 to 300 of about 1,013,409 (346)

The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies. [PDF]

PLoS One
Atilgan E, Türkmen Ceylan FB, Doruk ÖT, Ertuğrul HM, Barak AY.   +4 more
europepmc   +1 more source

Role of health workers and representative health worker organisations in LMIC pharmaceutical policy: a scoping review protocol. [PDF]

BMJ Open
Eisenkraft Klein D, Noor MN, Eiwanger L, Linton J, Ellis U, Sriram V.   +5 more
europepmc   +1 more source

Editorial: Molecular mechanisms of ion channel activation and modulation. [PDF]

Front Physiol
Cui M, Zhang M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmaceutical Sciences—1968. A Literature Review of Pharmaceutics

Journal of Pharmaceutical Sciences, 1969
This review of the literature represents a comprehensive cross section of the research and development efforts in various selected disciplines of the pharmaceutical sciences. It is the ninth annual survey in the series (1–8). To compile it, numerous periodicals and selected sections of Chemical Abstracts were abstracted.
Peter D. Bernardo, Emanuel J. Russo
openaire   +3 more sources

Information Intervention in the Pharmaceutical Sciences

Medical Reference Services Quarterly, 2012
Professional guidelines state that higher-order thinking skills are a desirable outcome of pharmacy education. In this context, courses in pharmaceutics at the University of Southern California are taught in a learner-centered manner that requires use of chemical reference sources and interpretation of physicochemical information for drug molecules. To
Rebecca M. Romero, Amy J. Chatfield, Ian S. Haworth   +2 more
openaire   +3 more sources

Pharmaceutical sciences in 2020

Nature Reviews Drug Discovery, 2010
By 2020, current scientific, business and social challenges and developments — such as R&D productivity, increased regulatory stringency and ageing populations — are likely to substantially affect many aspects of the pharmaceutical sciences. Here, we present four potential future scenarios based on discussions with experts in the pharmaceutical ...
Hubert G. M. Leufkens, Kamal K. Midha, Vinod P. Shah, Pieter Stolk, Daan J.A. Crommelin, Luc Besançon   +5 more
openaire   +2 more sources

Pharmaceutical Regulatory Science

TitlePharmaceutical Regulatory Science Authors / Editors Editor: Dr. Ravi Shankar Tripathi Co-Editor: Dr. Pravin Badhe Contributing Authors: Sushmita Hiremath; Nikhil Gawas; Bono Naga Sudha; Thokala Ujwala Reddy; Kanchanam AshaDeepthi; Shaik Shabana; Dr. Vivek R. Mallurwar; Reema Sanghvi; Dr.
Dr. Ravi Shankar Tripathi, Sushmita Hiremath, Nikhil Gawas, Bono Naga Sudha, Thokala Ujwala Reddy, Kanchanam AshaDeepthi, Shaik Shabana, Dr. Vivek R. Mallurwar, Reema Sanghvi, Dr. Sivakumar Kullampalayam Krishnasamy., Dr. Abinaya Mouralidasse, Yarra Sai Phanindra, Mrs. Kandregula Kesava Uma Maheswari   +1 more
openaire   +1 more source